© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
September 14, 2021
The new PDUFA date for Nefecon will be December 15, 2021.
September 11, 2021
Updates to the ADA Standards of Medical Care emphasize the utility of SGLT2 inhibitors and GLP-1 agonists. Yet, initiation is lacking from prescribers.
September 02, 2021
Investigators urge patients undergoing hemodialysis to adhere to their COVID-19 vaccination schedules, as data show a low antibody response.
August 31, 2021
Now that the agent shows benefit in mitigating comorbid risks, the expert advocates for more timely diagnoses and treatment initiation.
August 28, 2021
Incidence of death from cardiovascular causes was lower in the finerenone group (458 of 3686 patients) compared to the placebo group (519 of 3666 patients).
August 26, 2021
The new SLE test enhances specificity without sacrificing sensitivity.
July 29, 2021
The FDA noted the extent of the treatment effect of tenapanor is of unclear clinical significance, despite evidence of efficacy.
July 27, 2021
The priorities established by a panel of experts are designed to improve efficacy and equity in kidney research and care.
July 16, 2021
The treatment met all 5 primary efficacy endpoints as part of the ASCEND program.
July 15, 2021
The FDA Cardiovascular and Renal Drugs Advisory Committee cited concerns over an increase in thrombotic events.